Carmignac Gestion Edwards Lifesciences Corp Transaction History

Carmignac Gestion

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $957,692 - $1.1 Million	-12,172 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $389,635 - $495,835	-5,435 Reduced 30.87%	12,172 $1.11 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $1.06 Million - $1.38 Million	-15,805 Reduced 47.3%	17,607 $1.4 Million
Q2 2020 Aug 13, 2020	SELL	$57.54 - $76.95 $26.7 Million - $35.7 Million	-463,955 Reduced 93.28%	33,412 $2.3 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $26.1 Million - $40.3 Million	497,367 New	497,367 $93.8 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.